key: cord-0761490-5dhvs6id authors: Mansoor, Tarab; Alsarah, Ali A.; Mousavi, Hossein; Elyias, Javed; Girotra, Tarun; Hussein, Omar title: COVID-19 Associated Reversible Cerebral Vasoconstriction Syndrome Successfully Treated with Nimodipine and Aspirin date: 2021-04-12 journal: J Stroke Cerebrovasc Dis DOI: 10.1016/j.jstrokecerebrovasdis.2021.105822 sha: 6a8965920b95e039300bc49cbb99ddf60edc87df doc_id: 761490 cord_uid: 5dhvs6id There have been limited cases linking SARS-CoV-2 infection with the development of reversible cerebral vasoconstriction syndrome (RCVS). We hereby report a rare case of RCVS in the setting of mild SARS-CoV-2 respiratory infection successfully treated with nimodipine and aspirin. SARS-CoV-2 attacks the ACE2-receptors, which are expressed in various body organs including the lungs, kidneys, and blood vessels. Vasoconstriction can result from down-regulation of the ACE2-receptors that can lead to sympathetic hypertonia and/or over-activation of the renin-angiotensin axis. This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. There have been limited cases linking SARS-CoV-2 infection with the development of reversible cerebral vasoconstriction syndrome (RCVS). We hereby report a rare case of RCVS in the setting of mild SARS-CoV-2 respiratory infection successfully treated with nimodipine and aspirin. SARS-CoV-2 attacks the ACE2-receptors, which are expressed in various body organs including the lungs, kidneys, and blood vessels. Vasoconstriction can result from down-regulation of the ACE2-receptors that can lead to sympathetic hypertonia and/or over-activation of the renin-angiotensin axis. A 31-year-old sexually active, non-smoker female with a past medical history of spina-bifida and idiopathic thoracolumbar scoliosis status post hardware spinal fusion surgery five years ago presented with a one-day history of severe holocranial headaches associated with nausea and visual changes. A thorough neurological examination was intact. She complained of mild cough as well. She had a positive nasopharyngeal swab for SARS-CoV-2 on RT-PCR assay. A comprehensive drug screen including amphetamines, cocaine, nicotine, alcohol, and ecstasy as well as a pregnancy test were negative; coagulation profile was within normal limits. She was normotensive during her entire hospital stay. CTscan/head did not show signs of intracranial hemorrhage or ischemia. MRI-brain showed bilateral patchy gyral-pattern of T2-FLAIR hyperintensities, predominantly within the parieto-occipital lobes, and the frontal lobes Reversible cerebral vasoconstriction syndrome (RCVS) typically presents with symptoms of disabling recurrent thunderclap headaches. RCVS is characterized by segmental constriction of cerebral arteries that usually resolves within 3-12 weeks due to a transient disturbance in the control of cerebrovascular tone. RCVS may result in permanent disability. Complications from RCVS include posterior reversible encephalopathy syndrome (PRES), seizures, ischemic stroke, convexity subarachnoid hemorrhage (cSAH), and intraparenchymal hemorrhage. The identified triggers of RCVS include post-partum state, recreational, adrenergic, or serotonergic drugs. Angiographic diagnosis of RCVS made within 2-3 weeks of the clinical onset is imperative, as cerebral vasoconstriction is at a maximum during this period (1). Since the emergence of the novel SARS-CoV-2 virus, it has been linked to various cerebrovascular phenomena. There have been limited cases of related RCVS (2). However, SARS-CoV-2 may lead to global or segmental cerebral vasoconstriction with subsequent compromise of the cerebralautoregulation. It is not directly attributed to the infection itself. It may be attributed to SARS-CoV-2 down-regulation of the ACE2-receptors, which leads to sympathetic hypertonia and/or over-activation of the classic renin-angiotensin axis that leads to vasoconstriction, thus, precipitating RCVS (3). Our case also responded well to nimodipine and aspirin without development of further complications. This is merely an observation and should not be considered an association until further studied. Our case report has its limitations. One such limitation is the lack of more reported cases and established data about the association of RCVS and SARS-CoV-2 infection. This is possibly due to the unfamiliarity of the RCVS diagnosis compared to other diagnoses like stroke. Additional case reports will help us establish a definite causal relationship between RCVS and SARS-CoV-2 infection. However, there is adequate data about the pathophysiological processes associated with SARS-CoV-2 infection, which helps illustrate the likely mechanism of RCVS development in patients with concomitant SRAS-COV-2 infection. Vascular complications in symptomatic or mildly symptomatic respiratory cases of COVID-19, like the case we presented, is poorly described in literature. Although there is a positive correlation between the risk of vascular thrombosis and the severity of the COVID-19 disease (4), it is not unheard of to have vascular complications in mild cases of COVID-19 infection as well (5) . Reversible cerebral vasoconstriction syndrome Reversible cerebral vasoconstriction syndrome and dissection in the setting of COVID-19 infection Downregulation of Membrane-bound Angiotensin Converting Enzyme 2 (ACE2) Receptor has a Pivotal Role in COVID-19 Immunopathology COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation High prevalence of occult thrombosis in cases of mild/moderate COVID-19 The authors report no disclosures, conflicts of interest, or funding related to this project.